Knutsen; Lars Jacob Stray

Patent Applications and Registrations

Patent applications and USPTO patent grants for Knutsen; Lars Jacob Stray.The latest application filed is for "aantihistamines in combination with a range of substances for improved health".

Company Profile

1.6.9

Knutsen; Lars Jacob Stray - West Chester PA
Knutsen; Lars Jacob Stray - Wokingham GB
Knutsen; Lars Jacob Stray - Berkshire GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
AAntihistamines In Combination With A Range Of Substances For Improved Health App 20220133741 - Knutsen; Lars Jacob Stray ; et al.	2022-05-05
Antihistamines in combination with a range of substances for improved health Grant 11,224,603 - Knutsen , et al. January 18, 2	2022-01-18
Antihistamines Combined with Dietary Supplements for Improved Health App 20190008188 - Knutsen; Lars Jacob Stray ; et al.	2019-01-10
Antihistamines Combined with Dietary Supplements for Improved Health App 20170280749 - Knutsen; Lars Jacob Stray ; et al.	2017-10-05
Antihistamines combined with dietary supplements for improved health Grant 9,700,548 - Knutsen , et al. July 11, 2	2017-07-11
Antihistamines In Combination With A Range Of Substances For Improved Health App 20160317554 - Knutsen; Lars Jacob Stray ; et al.	2016-11-03
Preparations for the Treatment of Sleep-Related Respiratory Disorders App 20160008334 - Knutsen; Lars Jacob Stray ; et al.	2016-01-14
Combination Nutritional And Nutraceutical Products App 20150125548 - Knutsen; Lars Jacob Stray ; et al.	2015-05-07
Antihistamines Combined with Dietary Supplements for Improved Health App 20140199417 - Knutsen; Lars Jacob Stray ; et al.	2014-07-17
Method for the Treatment of Neuropathies Associated with Charcot-Marie-Tooth 1A (CMT1A) Disease App 20140080787 - Inglese; James ; et al.	2014-03-20
4-quinolinemethanol derivatives as purine receptor antagonists (II) Grant 6,608,085 - Gillespie , et al. August 19, 2	2003-08-19
4-Quinolinemethanol derivatives as purine receptor antagonists (1) Grant 6,583,156 - Gillespie , et al. June 24, 2	2003-06-24
(-)-mefloquine to block puringergic receptors and to treat movement or neurodegenerative disorders Grant 6,197,788 - Fletcher , et al. March 6, 2	2001-03-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.